Top Markets
Coin of the day
Duality Biotherapeutics, Inc. Duality Biotherapeutics, Inc.

Duality Biotherapeutics, Inc.

9606
Rank in Stocks #6046
Operating as a clinical-stage enterprise, Duality Biotherapeutics, Inc.... Operating as a clinical-stage enterprise, Duality Biotherapeutics, Inc. concentrates on pioneering next-generation antibody-drug conjugate (ADC) therapies and proprietary duality immune toxin antibody conjugate (ITAC) solutions. The firm was founded by Zhu Zhong Yuan on July 3, 2019, and its main offices are situated in Shanghai, China.
Share Price
$25.01
Market Cap
$2.26B
Change (1 day)
-1.21%
Change (1 year)
-37.74%
Country
CN
Trade Duality Biotherapeutics, Inc. (9606)

Category

P/S ratio for Duality Biotherapeutics, Inc. (9606)
P/S ratio as of 2026 TTM: 0
According to Duality Biotherapeutics, Inc. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for Duality Biotherapeutics, Inc. from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
10.17 -
US
10.13 -
NL
2.95 -
AU
11.28 -
US
- -
CH